United States regulators have for the first time approved a drug that can slow the progression of Alzheimer's disease, the most common type of dementia, offering hope for the growing pool of such patients here as well.
Current medications are able to treat just the symptoms of Alzheimer's, a disease which robs patients of their memory and cognitive abilities as the cells in their brains that process, store and retrieve information degenerate and die.
Please subscribe or log in to continue reading the full article.
Get unlimited access to all stories at $0.99/month
- Latest headlines and exclusive stories
- In-depth analyses and award-winning multimedia content
- Get access to all with our no-contract promotional package at only $0.99/month for the first 3 months*
*Terms and conditions apply.
More...